Investors

Growing Shareholder Value

Press Releases

Abiomed to Hold Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference

Nov 25, 2020
Read More
Additional Formats
PDF Version

Abiomed to Hold Fireside Chat at the Stephens Annual Investment Conference 2020

Nov 11, 2020
Read More
Additional Formats
PDF Version

First 1,000 Patients Treated with Impella 5.5 with SmartAssist, a Heart Pump Designed for Surgeons

Nov 05, 2020
Read More
Additional Formats
PDF Version

Abiomed Announces Q2 FY 2021 Revenue of $210 Million, Up 27% Over Q1 FY 2021 and Up 2% Over Q2 FY 2020 With 29.2% Operating Margin

Oct 29, 2020
Read More
Additional Formats
PDF Version

First Patients Treated with the World’s Smallest Heart Pump, the 9Fr Impella ECP

Oct 28, 2020
Read More
Additional Formats
PDF Version

FDA Grants 510(k) Clearance for Abiomed’s Innovative Cardiopulmonary Support Technology

Oct 26, 2020
Read More
Additional Formats
PDF Version

Studies Presented at TCT Connect Associate Higher Survival With Early Identification of Right Heart Failure and Early Use of Impella RP

Oct 16, 2020
Read More
Additional Formats
PDF Version

Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Cardiogenic Shock is Associated with Higher Survival, Particularly in Women

Oct 16, 2020
Read More
Additional Formats
PDF Version

Abiomed to Host a Virtual Meeting to Discuss New Clinical Data Presented at TCT Connect

Oct 15, 2020
Read More
Additional Formats
PDF Version

Largest Study of Hemodynamically Supported High-Risk PCI Patients Finds More Complete Revascularization with Impella Leads to Improved Outcomes

Oct 15, 2020
Read More
Additional Formats
PDF Version
View all